By Daniel R. Lucey MD, MPH, FIDSA In December, distinct SARS-CoV-2 virus variants with multiple mutations in the spike (S) protein were reported in the UK (“B.1.1.7”) and South Africa (“B.1.351”), and then, on Jan. 10, in travelers from northern Brazil arriving in Japan (“B.1.1.248”). A crucial question is whether any COVID vaccine will have […]
Innovative approaches can help find vulnerable young women in need of HIV prevention services The following is a guest post by Michelle Li, MS, and Quinn Lewis, MIA, of Data.FI project In sub-Saharan Africa, adolescent girls and young women are disproportionately impacted by HIV and are more likely to become infected, compared to their male […]
HIV
Leader Needed to Fight Another Pandemic: HIV – While the COVID-19 pandemic has disrupted HIV services worldwide, the office of U.S. Global AIDS Coordinator has remained […]
Tuberculosis
In the six weeks before South Africa responded its first diagnoses of COVID-19 with the start of physical distancing measures, more than 47,000 people on average […]
Research & Development
By Mitchell Warren, executive director, AVAC In February 2020, just as the COVID pandemic began its rapid global spread, a major HIV vaccine trial called HVTN […]
Policy
By Karen Carvajal, M.D. Over the course of human history we have come a long way in our fight against the threat of infectious diseases and, […]